Online citations, reference lists, and bibliographies.
← Back to Search

BP-C1 In Treatment Of Patients With Stage IV Breast Cancer: A Randomized, Double-blind, Placebo-controlled Multicenter Study And Additional Open-label Treatment Phase.

S. Larsén, A. Manikhas, E. Trishkina, M. Matrosova, Elena Poddubuskaya, S. Jensen
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
e12086 Background: The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatium (II) (BP-C1) versus equal looking placebo and to in...
This paper references
Panel on Handling Missing Data in Clinical Trials and Committee on National Statistics, editor
Conclusions (2010)
10.1177/014107689108401207
Breast Liver Metastases – Incidence, Diagnosis and Outcome
A. L. Hoe (1991)
10.1155/2013/456409
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
J. Lao (2013)
10.1093/annonc/mdp322
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch (2009)
10.1016/S0748-7983(03)00074-X
Disease-free survival after resection of lung metastases in patients with breast cancer.
C. Ludwig (2003)
10.1023/A:1005818323996
Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer
W. Boogerd (2004)
10.1038/bjc.1994.259
Continuous 5-fluorouracil in the treatment of breast cancer.
D. Cameron (1994)
10.1002/SIM.1519
Last observation carry-forward and last observation analysis.
J. Shao (2003)
10.1200/JCO.2010.34.5579
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
L. Carey (2012)
10.1007/s00259-004-1538-5
The curability of breast cancer and the treatment of advanced disease
V. Guarneri (2004)
10.1200/JCO.1988.6.12.1811
Cisplatin as first-line therapy for metastatic breast cancer.
G. Sledge (1988)
10.3109/0284186X.2014.921727
Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
M. Tuxen (2014)
10.1016/S0140-6736(05)66544-0
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (2005)
Patients with breast cancer are treated at home
L. Poulsen (2014)
Using Multivariate Statistics
B. Tabachnick (1983)
10.1634/THEONCOLOGIST.11-4-325
Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer.
W. Ershler (2006)
10.1371/journal.pone.0085156
Benzene-Poly-Carboxylic Acid Complex, a Novel Anti-Cancer Agent Induces Apoptosis in Human Breast Cancer Cells
F. Fares (2014)
10.1007/978-0-387-74039-3_1
Overview of resistance to systemic therapy in patients with breast cancer.
A. González-Angulo (2007)
Interaction of 3H-Labeled Benzene-Polycarboxylic Acids (BP-Cx-1) with Tumours and Normal Cell Cultures
IV Perminova (2012)
10.1111/j.1398-9995.1993.tb00741.x
Loratadine and terfenadine in perennial allergic rhinitis
K. Carlsen (1993)
10.3322/caac.20073
Cancer Statistics, 2010
A. Jemal (2010)
10.1136/bmj.g366
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
A. Miller (2014)
10.2307/2348741
Categorical Data Analysis.
D. Lendrem (1991)
10.1200/JCO.2013.53.7142
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
L. Shulman (2014)
Panel members. Threshold for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer
A Goldhirsch (2009)
10.3109/0284186X.2013.865076
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
C. Jørgensen (2014)
10.1007/s12282-011-0276-3
Improvement of survival and prospect of cure in patients with metastatic breast cancer
Y. Cheng (2011)
10.1634/THEONCOLOGIST.4-1-17
Monotherapy of metastatic breast cancer: a review of newer agents.
C. Vogel (1999)
10.2174/1876817220130613001
Benzene-Poly-Carboxylic Acids Complex with Cis-Diammineplatinum (II) Dichloride in the Treatment of Stage IV Breast Cancer Patients
S. Dewi (2013)
10.2307/2987660
Clinical Trials: A Practical Approach
S. Pocock (1984)
10.2307/2532320
Practical statistics for medical research
D. Altman (1990)



Semantic Scholar Logo Some data provided by SemanticScholar